Jeffrey Gelfand, MD

Title(s)Associate Professor, Neurology
SchoolSchool of Medicine
Address675 Nelson Rising Lane, #221B
San Francisco CA 94158
Phone415-502-7215
ORCID ORCID Icon0000-0002-5121-3319 Additional info
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoMAS2013Advanced Training in Clinical Research
    Harvard Medical SchoolM.D.2006
    Princeton UniversityA.B.2001History
    University of California, San Francisco, CA2018Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    American Academy of Neurology2021A.B. Baker Teacher Recognition Award
    UCSF School of Medicine2021PISCES Preceptor award
    UCSF2020Inducted into the Haile T. Debas Academy of Medical Educators
    National Multiple Sclerosis Society -- Northern California Chapter2019MS Physician of the Year
    AAN2016Elected as a Fellow of the American Academy of Neurology (FAAN)
    UCSF School of Medicine2015Excellence in Teaching Award -- Haile T. Debas Academy of Medical Educators
    UCSF Department of Neurology2014Robert B. Layzer Award for Resident Teaching
    SF Neurological Society2011Newman Award
    SF Neurological Society2009Newman Award
    Princeton University2001Summa Cum Laude and Phi Beta Kappa
    Princeton University2001Walter Phelps Hall Prize for the Best Thesis in European History

    Collapse Overview 
    Collapse Overview
    Dr. Gelfand is an Associate Professor of Neurology at UCSF. He specializes in caring for patients with a wide range of neuroinflammatory and neurodegenerative disorders. Dr. Gelfand conducts clinical research, including clinical trials, focused on advancing new treatments for neuroimmunological diseases and restoring neurological function. Dr. Gelfand is also an award-winning medical educator.

    Dr. Gelfand received an A.B. in history from Princeton University, graduating summa cum laude and Phi Beta Kappa. He received his M.D. from Harvard Medical School. He completed an internship in internal medicine, residency in neurology, and subspecialty fellowship training in MS/neuroimmunology, all at UCSF. Dr. Gelfand went on to earn a Masters in Advanced Study in clinical research at UCSF. He is board-certified in Neurology.

    Dr. Gelfand serves as Medical Director of the UCSF MS and Neuroinflammation Clinic. Dr. Gelfand is also the clinical director of the UCSF Center for Encephalitis and Meningitis (CEM). He is a Coach medical educator in the UCSF Medical School Bridges curriculum. Dr. Gelfand is a recipient of the Robert B. Layzer teaching award (2014), which is voted on annually by UCSF Neurology Department residents; an Excellence in Teaching Award from the UCSF Haile T. Debas Academy of Medical Educators (2015); and was inducted into the UCSF Haile T. Debas Academy of Medical Educators (2020). He served as the Program Director of the UCSF MS Center Clinical Fellowship Training Program for a decade (through 2023), helping to train a new generation of specialists in the field.

    Dr. Gelfand is a Fellow of the American Academy of Neurology (FAAN). In 2023 he was elected Chair of the American Academy of Neurology Autoimmune Neurology section.

    Collapse ORNG Applications 
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Low Referral Rates for Pelvic Floor Physical Therapy in MS Patients with Bladder Dysfunction: An Opportunity to Close the Gap. Multiple Sclerosis and Related Disorders. 2024 Jun 1; 86:105592. Winawer WI, Bove BR, Keyan KZ, Cree CB, Gelfand GJ, Block BV. .
      View in: Publisher Site   Mentions:
    2. Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis. JAMA Neurol. 2024 Mar 11. Cross AH, Gelfand JM, Thebault S, Bennett JL, von Büdingen HC, Cameron B, Carruthers R, Edwards K, Fallis R, Gerstein R, Giacomini PS, Greenberg B, Hafler DA, Ionete C, Kaunzner UW, Kodama L, Lock C, Longbrake EE, Musch B, Pardo G, Piehl F, Weber MS, Yuen S, Ziemssen T, Bose G, Freedman MS, Anania VG, Ramesh A, Winger RC, Jia X, Herman A, Harp C, Bar-Or A. PMID: 38466277; PMCID: PMC10928543.
      View in: PubMed   Mentions:    Fields:    
    3. Clinical presentation and diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: a literature analysis of case studies. Front Neurol. 2024; 15:1320663. Papapetropoulos S, Gelfand JM, Konno T, Ikeuchi T, Pontius A, Meier A, Foroutan F, Wszolek ZK. PMID: 38529036; PMCID: PMC10962389.
      View in: PubMed   Mentions:
    4. Development of an LC-MS/MS Method to Measure Sphingolipids in CSF from Patients with Multiple Sclerosis. Mol Pharmacol. 2024 Feb 15; 105(3):121-130. Perez-Paramo YX, Dufield D, Veeramachaneni R, Parkhurst E, Harp C, Ramesh A, Winger RC, Cross AH, Gelfand JM, Bar-Or A, Mathews WR, Anania VG. PMID: 38182433.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. A Closed-Loop Falls Monitoring and Prevention App for Multiple Sclerosis Clinical Practice: Human-Centered Design of the Multiple Sclerosis Falls InsightTrack. JMIR Hum Factors. 2024 Jan 11; 11:e49331. Block VJ, Koshal K, Wijangco J, Miller N, Sara N, Henderson K, Reihm J, Gopal A, Mohan SD, Gelfand JM, Guo CY, Oommen L, Nylander A, Rowson JA, Brown E, Sanders S, Rankin K, Lyles CR, Sim I, Bove R. PMID: 38206662; PMCID: PMC10811573.
      View in: PubMed   Mentions: 2  Translation:Humans
    6. "Self-care selfies": Patient-uploaded videos capture meaningful changes in dexterity over 6 months. Ann Clin Transl Neurol. 2023 12; 10(12):2394-2406. Gopal A, Torres WO, Winawer I, Poole S, Balan A, Stuart HS, Fritz NE, Gelfand JM, Allen DD, Bove R. PMID: 37877622; PMCID: PMC10723247.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Detection of High-Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins. Ann Neurol. 2023 12; 94(6):1086-1101. Bartley CM, Ngo TT, Do LD, Zekeridou A, Dandekar R, Muñiz-Castrillo S, Alvarenga BD, Zorn KC, Tubati A, Pinto AL, Browne WD, Hullett PW, Terrelonge M, Schubert RD, Piquet AL, Yang B, Montalvo M, Kung AF, Mann SA, Shah MP, Geschwind MD, Gelfand JM, DeRisi JL, Pittock SJ, Honnorat J, Pleasure SJ, Wilson MR. PMID: 37632288; PMCID: PMC10842626.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Fall Assessment and Monitoring in People With Multiple Sclerosis: A Practical Evidence-Based Review for Clinicians. Neurol Clin Pract. 2023 Oct; 13(5):e200184. Gopal A, Gelfand JM, Bove R, Block VJ. PMID: 37720138; PMCID: PMC10503932.
      View in: PubMed   Mentions: 1  
    9. Characteristics of Progressive Multifocal Leukoencephalopathy Associated With Sarcoidosis Without Therapeutic Immune Suppression. JAMA Neurol. 2023 06 01; 80(6):624-633. McEntire CRS, Fletcher A, Toledano M, Epstein S, White E, Tan CS, Mao-Draayer Y, Banks SA, Aksamit AJ, Gelfand JM, Thakur KT, Anand P, Cortese I, Bhattacharyya S. PMID: 37093609; PMCID: PMC10126944.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. A Predictive Autoantibody Signature in Multiple Sclerosis. medRxiv. 2023 May 15. Zamecnik CR, Sowa GM, Abdelhak A, Dandekar R, Bair RD, Wade KJ, Bartley CM, Tubati A, Gomez R, Fouassier C, Gerungan C, Alexander J, Wapniarski AE, Loudermilk RP, Eggers EL, Zorn KC, Ananth K, Jabassini N, Mann SA, Ragan NR, Santaniello A, Henry RG, Baranzini SE, Zamvil SS, Bove RM, Guo CY, Gelfand JM, Cuneo R, von Büdingen HC, Oksenberg JR, Cree BA, Hollenbach JA, Green AJ, Hauser SL, Wallin MT, DeRisi JL, Wilson MR. PMID: 37205595; PMCID: PMC10187343.
      View in: PubMed   Mentions:
    11. Association of Daily Physical Activity with Cervical Spinal Cord Areas in Multiple Sclerosis. Multiple Sclerosis and Related Disorders. 2023 May 1; 73:104650. Block BV, Cheng CS, Juwono JJ, Cuneo CR, Kirkish KG, Alexander AA, Khan KM, Akula AA, Caverzasi CE, Papinutto PN, Stern SW, San Francisco MS-EPIC Team University of California S, Pletcher PM, Marcus MG, Olgin OJ, Hauser HS, Gelfand GJ, Bove BR, Cree CB, Henry HR. .
      View in: Publisher Site   Mentions:
    12. Autoimmune Encephalitis Consensus Criteria: Lessons Learned From Real-World Practice. Neurol Clin Pract. 2023 Jun; 13(3):e200155. Gelfand JM, Guo CY. PMID: 37124462; PMCID: PMC10132259.
      View in: PubMed   Mentions:
    13. Dual ankyrinG and subpial autoantibodies in a man with well-controlled HIV infection with steroid-responsive meningoencephalitis: A case report. Front Neurol. 2022; 13:1102484. Bartley CM, Ngo TT, Cadwell CR, Harroud A, Schubert RD, Alvarenga BD, Hawes IA, Zorn KC, Hunyh T, Teliska LH, Kung AF, Shah S, Gelfand JM, Chow FC, Rasband MN, Dubey D, Pittock SJ, DeRisi JL, Wilson MR, Pleasure SJ. PMID: 36756346; PMCID: PMC9900111.
      View in: PubMed   Mentions: 2  
    14. Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proc Natl Acad Sci U S A. 2023 01 17; 120(3):e2207291120. Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson KR, Kakara M, Zuroff L, Bennett JL, von Büdingen HC, Carruthers R, Edwards KR, Fallis R, Giacomini PS, Greenberg BM, Hafler DA, Ionete C, Kaunzner UW, Lock CB, Longbrake EE, Pardo G, Piehl F, Weber MS, Ziemssen T, Jacobs D, Gelfand JM, Cross AH, Cameron B, Musch B, Winger RC, Jia X, Harp CT, Herman A, Bar-Or A. PMID: 36634138; PMCID: PMC9934304.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    15. Autoimmune Encephalitis Misdiagnosis in Adults. JAMA Neurol. 2023 01 01; 80(1):30-39. Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, Zitser J, Gelfand JM, Day GS, Dunham SR, Rodenbeck SJ, Clardy SL, Solomon AJ, Pittock SJ, McKeon A, Dubey D, Zekeridou A, Toledano M, Turner LE, Vernino S, Irani SR. PMID: 36441519; PMCID: PMC9706400.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    16. Remote Observational Research for Multiple Sclerosis: A Natural Experiment. Neurol Neuroimmunol Neuroinflamm. 2023 03; 10(2). Bove R, Poole S, Cuneo R, Gupta S, Sabatino J, Harms M, Cooper T, Rowles W, Miller N, Gomez R, Lincoln R, McPolin K, Powers K, Santaniello A, Renschen A, Bevan CJ, Gelfand JM, Goodin DS, Guo CY, Romeo AR, Hauser SL, Campbell Cree BA, UCSF MS-EPIC Team. PMID: 36585249; PMCID: PMC9808915.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    17. Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosis. Mult Scler. 2023 03; 29(3):363-373. Block VJ, Cheng S, Juwono J, Cuneo R, Kirkish G, Alexander AM, Khan M, Akula A, Caverzasi E, Papinutto N, Stern WA, Pletcher MJ, Marcus GM, Olgin JE, Hauser SL, Gelfand JM, Bove R, Cree BA, Henry RG. PMID: 36573559; PMCID: PMC9972237.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course. Cell. 2022 09 15; 185(19):3467-3486.e16. iMSMS Consortium. Electronic address: sergio.baranzini@ucsf.edu, iMSMS Consortium. PMID: 36113426; PMCID: PMC10143502.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    19. Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2022 Jun 16. Abdelhak A, Cordano C, Boscardin WJ, Caverzasi E, Kuhle J, Chan B, Gelfand JM, Yiu HH, Oertel FC, Beaudry-Richard A, Condor Montes S, Oksenberg JR, Lario Lago A, Boxer A, Rojas-Martinez JC, Elahi FM, Chan JR, Green AJ. PMID: 35710320; PMCID: PMC9984688.
      View in: PubMed   Mentions: 3     Fields:    
    20. Making Every Step Count: Minute-by-Minute Characterization of Step Counts Augments Remote Activity Monitoring in People With Multiple Sclerosis. Front Neurol. 2022; 13:860008. Block VJ, Waliman M, Xie Z, Akula A, Bove R, Pletcher MJ, Marcus GM, Olgin JE, Cree BAC, Gelfand JM, Henry RG. PMID: 35677343; PMCID: PMC9167929.
      View in: PubMed   Mentions: 1  
    21. Transitioning From S1P Receptor Modulators to B Cell-Depleting Therapies in Multiple Sclerosis: Clinical, Radiographic, and Laboratory Data. Neurol Neuroimmunol Neuroinflamm. 2022 07; 9(4). Rowles WM, Hsu WY, McPolin K, Li A, Merrill S, Guo CY, Green AJ, Gelfand JM, Bove RM. PMID: 35581005; PMCID: PMC9128034.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trial. Mult Scler Relat Disord. 2022 May; 61:103747. Bove R, Anderson A, Rowles W, Rankin KA, Hills NK, Carleton M, Cooper J, Cree BAC, Gelfand JM, Graves JS, Henry RG, Krysko KM, Rush G, Zamvil SS, Joffe H, Chan JR, Green AJ. PMID: 35397292.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    23. Human Leukocyte Antigen Association Study Reveals DRB1*04:02 Effects Additional to DRB1*07:01 in Anti-LGI1 Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2022 03; 9(2). Peris Sempere V, Muñiz-Castrillo S, Ambati A, Binks S, Pinto AL, Rogemond V, Pittock SJ, Dubey D, Geschwind MD, Gelfand JM, Dilwali S, Lee ST, Knight J, Elliott KS, Irani S, Honnorat J, Mignot E. PMID: 35115410; PMCID: PMC8815287.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    24. Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis. Ann Neurol. 2022 02; 91(2):268-281. Bischof A, Papinutto N, Keshavan A, Rajesh A, Kirkish G, Zhang X, Mallott JM, Asteggiano C, Sacco S, Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello A, Zhu AH, Juwono J, Bevan CJ, Bove RM, Crabtree E, Gelfand JM, Goodin DS, Graves JS, Green AJ, Oksenberg JR, Waubant E, Wilson MR, Zamvil SS, University of California, San Francisco MS-EPIC Team, Cree BAC, Hauser SL, Henry RG. PMID: 34878197; PMCID: PMC8916838.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    25. Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid. JAMA Neurol. 2021 11 01; 78(11):1355-1366. Gu W, Rauschecker AM, Hsu E, Zorn KC, Sucu Y, Federman S, Gopez A, Arevalo S, Sample HA, Talevich E, Nguyen ED, Gottschall M, Nourbakhsh B, Gold CA, Cree BAC, Douglas VC, Richie MB, Shah MP, Josephson SA, Gelfand JM, Miller S, Wang L, Tihan T, DeRisi JL, Chiu CY, Wilson MR. PMID: 34515766; PMCID: PMC8438621.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    26. ANA Investigates Therapeutic Advancements in Neuroimmunology. Ann Neurol. 2021 11; 90(5):720-721. Samudralwar RD, Goss AL, Richie M, Gelfand JM. PMID: 34561891.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Neurosarcoidosis: Pathophysiology, Diagnosis, and Treatment. Neurol Neuroimmunol Neuroinflamm. 2021 11; 8(6). Bradshaw MJ, Pawate S, Koth LL, Cho TA, Gelfand JM. PMID: 34607912; PMCID: PMC8495503.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    28. Glucocorticoids for therapeutic immunosuppression: Clinical pearls for the practicing neurologist. J Neurol Sci. 2021 Nov 15; 430:120004. Galati A, Brown ES, Bove R, Vaidya A, Gelfand J. PMID: 34598056.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    29. Identifying falls remotely in people with multiple sclerosis. J Neurol. 2022 Apr; 269(4):1889-1898. Block VJ, Pitsch EA, Gopal A, Zhao C, Pletcher MJ, Marcus GM, Olgin JE, Hollenbach J, Bove R, Cree BAC, Gelfand JM. PMID: 34405267; PMCID: PMC8370664.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    30. Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology. Neurol Clin Pract. 2021 Aug; 11(4):352-357. Hua LH, Obeidat AZ, Amezcua L, Cohen JA, Costello K, Dunn J, Gelfand JM, Goldman MD, Hopkins S, Jeffery D, Krieger S, Newsome SD, Shah S, Sicotte NL, Yadav V, Longbrake EE. PMID: 34484933; PMCID: PMC8382436.
      View in: PubMed   Mentions:
    31. Foundational Telemedicine Workshop for First-Year Medical Students Developed During a Pandemic. MedEdPORTAL. 2021; 17:11171. Cornes S, Gelfand JM, Calton B. PMID: 34337148; PMCID: PMC8282677.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsPHPublic Health
    32. Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors. J Immunother Cancer. 2021 07; 9(7). Guidon AC, Burton LB, Chwalisz BK, Hillis J, Schaller TH, Amato AA, Betof Warner A, Brastianos PK, Cho TA, Clardy SL, Cohen JV, Dietrich J, Dougan M, Doughty CT, Dubey D, Gelfand JM, Guptill JT, Johnson DB, Juel VC, Kadish R, Kolb N, LeBoeuf NR, Linnoila J, Mammen AL, Martinez-Lage M, Mooradian MJ, Naidoo J, Neilan TG, Reardon DA, Rubin KM, Santomasso BD, Sullivan RJ, Wang N, Woodman K, Zubiri L, Louv WC, Reynolds KL. PMID: 34281989; PMCID: PMC8291304.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    33. Effects of COVID-19 "Sheltering in Place" on Activity in People With Multiple Sclerosis. Neurol Clin Pract. 2021 Apr; 11(2):e216-e218. Block VJ, Bove R, Gelfand JM, Cree BAC. PMID: 33842099; PMCID: PMC8032435.
      View in: PubMed   Mentions: 4  
    34. Tumour necrosis factor inhibitor monotherapy for CNS neurosarcoidosis. J Neurol Neurosurg Psychiatry. 2021 Mar 30. Gelfand JM. PMID: 33785576.
      View in: PubMed   Mentions:    Fields:    
    35. UpToDate. Neurologic and neuropsychiatric manifestations of systemic lupus erythematosus. 2021. Jeffrey M. Gelfand, Jinoos Yazdany.
    36. UpToDate. Manifestations of systemic lupus erythematosus affecting the peripheral nervous system. 2021. Jeffrey M. Gelfand, Jinoos Yazdany.
    37. CoachMS, an innovative closed-loop, interdisciplinary platform to monitor and proactively treat MS symptoms: A pilot study. Mult Scler J Exp Transl Clin. 2021 Jan-Mar; 7(1):2055217321988937. Block VJ, Gopal A, Rowles W, -Yueh C, Gelfand JM, Bove R. PMID: 33796329; PMCID: PMC7970691.
      View in: PubMed   Mentions: 4  
    38. Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology. Neurology Clinical Practice. 2021 Jan 25; 10.1212/cpj.0000000000001040. Hua HL, Obeidat OA, Amezcua AL, Cohen CJ, Costello CK, Dunn DJ, Gelfand GJ, Goldman GM, Hopkins HS, Jeffery JD, Krieger KS, Newsome NS, Shah SS, Sicotte SN, Yadav YV, Longbrake LE. .
      View in: Publisher Site   Mentions:
    39. CoachMS, an innovative closed-loop, interdisciplinary platform to monitor and proactively treat MS symptoms: A pilot study. Multiple Sclerosis Journal - Experimental Translational and Clinical. 2021 Jan 1; 7(1):205521732198893. Block BV, Gopal GA, Rowles RW, -Yueh -C, Gelfand GJ, Bove BR. .
      View in: Publisher Site   Mentions:
    40. Underutilization of physical therapy for symptomatic women with MS during and following pregnancy. Mult Scler Relat Disord. 2021 Feb; 48:102703. Block VJ, Mestas O, Anderson A, Singh J, Wylie L, Guo CY, Green AJ, Gelfand JM, Bove R. PMID: 33387862.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosis. Mult Scler. 2021 08; 27(9):1432-1441. Romeo AR, Rowles WM, Schleimer ES, Barba P, Hsu WY, Gomez R, Santaniello A, Zhao C, Pearce JR, Jones JB, Cree BC, Hauser SL, Gelfand JM, Stewart WF, Goodin DS, Bove RM. PMID: 33236967; PMCID: PMC8144241.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    42. Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis. Sci Immunol. 2020 11 20; 5(53). Pröbstel AK, Zhou X, Baumann R, Wischnewski S, Kutza M, Rojas OL, Sellrie K, Bischof A, Kim K, Ramesh A, Dandekar R, Greenfield AL, Schubert RD, Bisanz JE, Vistnes S, Khaleghi K, Landefeld J, Kirkish G, Liesche-Starnecker F, Ramaglia V, Singh S, Tran EB, Barba P, Zorn K, Oechtering J, Forsberg K, Shiow LR, Henry RG, Graves J, Cree BAC, Hauser SL, Kuhle J, Gelfand JM, Andersen PM, Schlegel J, Turnbaugh PJ, Seeberger PH, Gommerman JL, Wilson MR, Schirmer L, Baranzini SE. PMID: 33219152; PMCID: PMC8043673.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCells
    43. Retinal INL Thickness in Multiple Sclerosis: A Mere Marker of Neurodegeneration? Ann Neurol. 2021 01; 89(1):192-193. Cordano C, Yiu HH, Oertel FC, University of California, San Francisco MS-EPIC Team, Gelfand JM, Hauser SL, Cree BAC, Green AJ. PMID: 33067847; PMCID: PMC7990472.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    44. Effects of COVID-19 “Sheltering in Place” on Activity in People with Multiple Sclerosis. Neurology Clinical Practice. 2020 Sep 28; 10.1212/cpj.0000000000000982. Block BV, Bove BR, Gelfand GJ, Cree CB. .
      View in: Publisher Site   Mentions:
    45. A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis. Proc Natl Acad Sci U S A. 2020 09 15; 117(37):22932-22943. Ramesh A, Schubert RD, Greenfield AL, Dandekar R, Loudermilk R, Sabatino JJ, Koelzer MT, Tran EB, Koshal K, Kim K, Pröbstel AK, Banerji D, University of California, San Francisco MS-EPIC Team, Guo CY, Green AJ, Bove RM, DeRisi JL, Gelfand JM, Cree BAC, Zamvil SS, Baranzini SE, Hauser SL, Wilson MR. PMID: 32859762; PMCID: PMC7502747.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    46. Imaging correlates of visual function in multiple sclerosis. PLoS One. 2020; 15(8):e0235615. Caverzasi E, Cordano C, Zhu AH, Zhao C, Bischof A, Kirkish G, Bennett DJ, Devereux M, Baker N, Inman J, Yiu HH, Papinutto N, Gelfand JM, Cree BAC, Hauser SL, Henry RG, Green AJ. PMID: 32745132; PMCID: PMC7398529.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    47. Risk of Neuroinflammatory Adverse Events With Tumor Necrosis Factor Inhibitor Treatment. JAMA Neurol. 2020 08 01; 77(8):933-935. Gelfand JM, Yazdany J. PMID: 32421154.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    48. A Precision Medicine Tool for Patients With Multiple Sclerosis (the Open MS BioScreen): Human-Centered Design and Development. J Med Internet Res. 2020 07 06; 22(7):e15605. Schleimer E, Pearce J, Barnecut A, Rowles W, Lizee A, Klein A, Block VJ, Santaniello A, Renschen A, Gomez R, Keshavan A, Gelfand JM, Henry RG, Hauser SL, Bove R. PMID: 32628124; PMCID: PMC7381029.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    49. Anti-gamma-aminobutyric acid receptor type A encephalitis: a review. Curr Opin Neurol. 2020 06; 33(3):372-380. Guo CY, Gelfand JM, Geschwind MD. PMID: 32374573.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    50. Fixational microsaccades: A quantitative and objective measure of disability in multiple sclerosis. Mult Scler. 2020 03; 26(3):343-353. Sheehy CK, Bensinger ES, Romeo A, Rani L, Stepien-Bernabe N, Shi B, Helft Z, Putnam N, Cordano C, Gelfand JM, Bove R, Stevenson SB, Green AJ. PMID: 32031464.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    51. Intrathecal B-cell activation in LGI1 antibody encephalitis. Neurol Neuroimmunol Neuroinflamm. 2020 03; 7(2). Lehmann-Horn K, Irani SR, Wang S, Palanichamy A, Jahn S, Greenfield AL, Dandekar R, Lepennetier G, Michael S, Gelfand JM, Geschwind MD, Wilson MR, Zamvil SS, von Büdingen HC. PMID: 32029531; PMCID: PMC7051206.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    52. Allogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented glia. Brain. 2020 02 01; 143(2):503-511. Gelfand JM, Greenfield AL, Barkovich M, Mendelsohn BA, Van Haren K, Hess CP, Mannis GN. PMID: 31840744.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    53. Exploratory analysis of the potential for advanced diagnostic testing to reduce healthcare expenditures of patients hospitalized with meningitis or encephalitis. PLoS One. 2020; 15(1):e0226895. Fulton BD, Proudman DG, Sample HA, Gelfand JM, Chiu CY, DeRisi JL, Wilson MR. PMID: 31940319; PMCID: PMC6961903.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    54. Validation of a consumer-grade activity monitor for continuous daily activity monitoring in individuals with multiple sclerosis. Mult Scler J Exp Transl Clin. 2019 Oct-Dec; 5(4):2055217319888660. Block VJ, Zhao C, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Henry R, Gelfand JM, Cree BA. PMID: 31803492; PMCID: PMC6876176.
      View in: PubMed   Mentions: 11  
    55. Progressive Neurological Impairment and an Enhancing Brainstem Lesion in a Middle-aged Man. JAMA Neurol. 2019 Nov 01; 76(11):1397-1398. Gupta S, Damon L, Gelfand JM. PMID: 31524939.
      View in: PubMed   Mentions:    Fields:    
    56. Exploratory proteomic analysis implicates the alternative complement cascade in primary CNS vasculitis. Neurology. 2019 07 30; 93(5):e433-e444. Mandel-Brehm C, Retallack H, Knudsen GM, Yamana A, Hajj-Ali RA, Calabrese LH, Tihan T, Sample HA, Zorn KC, Gorman MP, Madan Cohen J, Sreih AG, Marcus JF, Josephson SA, Douglas VC, Gelfand JM, Wilson MR, DeRisi JL. PMID: 31270218; PMCID: PMC6693432.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    57. Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis. N Engl J Med. 2019 06 13; 380(24):2327-2340. Wilson MR, Sample HA, Zorn KC, Arevalo S, Yu G, Neuhaus J, Federman S, Stryke D, Briggs B, Langelier C, Berger A, Douglas V, Josephson SA, Chow FC, Fulton BD, DeRisi JL, Gelfand JM, Naccache SN, Bender J, Dien Bard J, Murkey J, Carlson M, Vespa PM, Vijayan T, Allyn PR, Campeau S, Humphries RM, Klausner JD, Ganzon CD, Memar F, Ocampo NA, Zimmermann LL, Cohen SH, Polage CR, DeBiasi RL, Haller B, Dallas R, Maron G, Hayden R, Messacar K, Dominguez SR, Miller S, Chiu CY. PMID: 31189036; PMCID: PMC6764751.
      View in: PubMed   Mentions: 351     Fields:    Translation:HumansCTClinical Trials
    58. Multiple sclerosis and sarcoidosis: A case for coexistence. Neurol Clin Pract. 2019 Jun; 9(3):218-227. Tyshkov C, Pawate S, Bradshaw MJ, Kimbrough DJ, Chitnis T, Gelfand JM, Ryerson LZ, Kister I. PMID: 31341709; PMCID: PMC6615652.
      View in: PubMed   Mentions: 5  
    59. GABAA receptor autoimmunity: A multicenter experience. Neurol Neuroimmunol Neuroinflamm. 2019 05; 6(3):e552. O'Connor K, Waters P, Komorowski L, Zekeridou A, Guo CY, Mgbachi VC, Probst C, Mindorf S, Teegen B, Gelfand JM, Geschwind MD, Lennon V, Pittock SJ, McKeon A. PMID: 31119187; PMCID: PMC6501640.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    60. Silent progression in disease activity-free relapsing multiple sclerosis. Ann Neurol. 2019 05; 85(5):653-666. University of California, San Francisco MS-EPIC Team, Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS, Gelfand JM, Graves J, Green AJ, Wilson MR, Zamvil SS, Zhao C, Gomez R, Ragan NR, Rush GQ, Barba P, Santaniello A, Baranzini SE, Oksenberg JR, Henry RG, Hauser SL. PMID: 30851128; PMCID: PMC6518998.
      View in: PubMed   Mentions: 130     Fields:    Translation:Humans
    61. Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis. JAMA Netw Open. 2019 03 01; 2(3):e190570. Block VJ, Bove R, Zhao C, Garcha P, Graves J, Romeo AR, Green AJ, Allen DD, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Cree BAC, Gelfand JM. PMID: 30874777; PMCID: PMC6484622.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    62. pRNFL as a marker of disability worsening in the medium/long term in patients with MS. Neurol Neuroimmunol Neuroinflamm. 2019 03; 6(2):e533. Cordano C, Nourbakhsh B, Devereux M, Damotte V, Bennett D, Hauser SL, Cree BAC, Gelfand JM, Green AJ. PMID: 30697584; PMCID: PMC6340330.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    63. Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol. 2018 12 01; 75(12):1546-1553. Stern BJ, Royal W, Gelfand JM, Clifford DB, Tavee J, Pawate S, Berger JR, Aksamit AJ, Krumholz A, Pardo CA, Moller DR, Judson MA, Drent M, Baughman RP. PMID: 30167654.
      View in: PubMed   Mentions: 110     Fields:    Translation:Humans
    64. A young man with numbness in arms and legs: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2018 Nov; 5(6):e509. Romeo AR, Lisak RP, Meltzer E, Fox EJ, Melamed E, Lucas A, Freeman L, Frohman TC, Costello K, Zamvil SS, Frohman EM, Gelfand JM. PMID: 30465017; PMCID: PMC6225923.
      View in: PubMed   Mentions: 1     Fields:    
    65. Clinic to in-home telemedicine reduces barriers to care for patients with MS or other neuroimmunologic conditions. Neurol Neuroimmunol Neuroinflamm. 2018 Nov; 5(6):e505. Bove R, Garcha P, Bevan CJ, Crabtree-Hartman E, Green AJ, Gelfand JM. PMID: 30775409; PMCID: PMC6354660.
      View in: PubMed   Mentions: 20     Fields:    
    66. Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis. Mult Scler. 2019 10; 25(11):1526-1534. Bove R, Bevan C, Crabtree E, Zhao C, Gomez R, Garcha P, Morrissey J, Dierkhising J, Green AJ, Hauser SL, Cree BA, Wallin MT, Gelfand JM. PMID: 30141729.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    67. Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing. JAMA Neurol. 2018 08 01; 75(8):947-955. Wilson MR, O'Donovan BD, Gelfand JM, Sample HA, Chow FC, Betjemann JP, Shah MP, Richie MB, Gorman MP, Hajj-Ali RA, Calabrese LH, Zorn KC, Chow ED, Greenlee JE, Blum JH, Green G, Khan LM, Banerji D, Langelier C, Bryson-Cahn C, Harrington W, Lingappa JR, Shanbhag NM, Green AJ, Brew BJ, Soldatos A, Strnad L, Doernberg SB, Jay CA, Douglas V, Josephson SA, DeRisi JL. PMID: 29710329; PMCID: PMC5933460.
      View in: PubMed   Mentions: 126     Fields:    Translation:HumansAnimalsCells
    68. Distinct HLA associations of LGI1 and CASPR2-antibody diseases. Brain. 2018 08 01; 141(8):2263-2271. Binks S, Varley J, Lee W, Makuch M, Elliott K, Gelfand JM, Jacob S, Leite MI, Maddison P, Chen M, Geschwind MD, Grant E, Sen A, Waters P, McCormack M, Cavalleri GL, Barnardo M, Knight JC, Irani SR. PMID: 29788256; PMCID: PMC6118231.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    69. Autoimmune encephalitis after herpes simplex encephalitis: insights into pathogenesis. Lancet Neurol. 2018 09; 17(9):733-735. Gelfand JM. PMID: 30049613.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    70. Reduced contrast sensitivity among older women is associated with increased risk of cognitive impairment. Ann Neurol. 2018 04; 83(4):730-738. Ward ME, Gelfand JM, Lui LY, Ou Y, Green AJ, Stone K, Pedula KL, Cummings SR, Yaffe K. PMID: 29518257; PMCID: PMC5947874.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    71. Migraine is common in patients with sarcoidosis. Cephalalgia. 2018 12; 38(14):2079-2082. Gelfand JM, Gelfand AA, Goadsby PJ, Benn BS, Koth LL. PMID: 29580067.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    72. Sleep disturbance and symptom burden in sarcoidosis. Respir Med. 2018 11; 144S:S35-S40. Benn BS, Lehman Z, Kidd SA, Miaskowski C, Sunwoo BY, Ho M, Sun S, Ramstein J, Gelfand JM, Koth LL. PMID: 29628134.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    73. Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD. Neurol Neuroimmunol Neuroinflamm. 2018 May; 5(3):e453. Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, Green AJ, Hauser SL, Bove R. PMID: 29564373; PMCID: PMC5858951.
      View in: PubMed   Mentions: 64     Fields:    
    74. The state of clinical research in neurology. Neurology. 2018 04 10; 90(15):e1347-e1354. Hall DA, Ramos AR, Gelfand JM, Videnovic A, Benatar M, Cahill C, Kluger BM, Goldman M. PMID: 29549220; PMCID: PMC5894931.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    75. The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain. 2018 02 01; 141(2):348-356. Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, Farooque P, Gelfand JM, Geschwind MD, Hirsch LJ, Somerville E, Lang B, Vincent A, Leite MI, Waters P, Irani SR, Faciobrachial Dystonic Seizures Study Group. PMID: 29272336; PMCID: PMC5837230.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansCells
    76. Harnessing electronic medical records to advance research on multiple sclerosis. Mult Scler. 2019 03; 25(3):408-418. Damotte V, Lizée A, Tremblay M, Agrawal A, Khankhanian P, Santaniello A, Gomez R, Lincoln R, Tang W, Chen T, Lee N, Villoslada P, Hollenbach JA, Bevan CD, Graves J, Bove R, Goodin DS, Green AJ, Baranzini SE, Cree BA, Henry RG, Hauser SL, Gelfand JM, Gourraud PA. PMID: 29310490.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    77. Pleocytosis is not fully responsible for low CSF glucose in meningitis. Neurol Neuroimmunol Neuroinflamm. 2018 Jan; 5(1):e425. Baud MO, Vitt JR, Robbins NM, Wabl R, Wilson MR, Chow FC, Gelfand JM, Josephson SA, Miller S. PMID: 29296633; PMCID: PMC5745359.
      View in: PubMed   Mentions: 6     Fields:    
    78. Demystifying Neurosarcoidosis and Informing Prognosis. JAMA Neurol. 2017 11 01; 74(11):1296-1298. Gelfand JM. PMID: 29052731.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    79. Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series. Neurology. 2017 Nov 14; 89(20):2092-2100. Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, Koth LL, Hauser SL, Dierkhising J, Vu N, Sriram S, Moses H, Bagnato F, Kaufmann JA, Ammah DJ, Yohannes TH, Hamblin MJ, Venna N, Green AJ, Pawate S. PMID: 29030454; PMCID: PMC5711506.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    80. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet. 2017 Dec 02; 390(10111):2481-2489. Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, Inman J, Arnow S, Devereux M, Abounasr A, Nobuta H, Zhu A, Friessen M, Gerona R, von Büdingen HC, Henry RG, Hauser SL, Chan JR. PMID: 29029896.
      View in: PubMed   Mentions: 184     Fields:    Translation:Humans
    81. Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis. Neurotherapeutics. 2017 Oct; 14(4):835-841. Gelfand JM, Cree BAC, Hauser SL. PMID: 28695471; PMCID: PMC5722762.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    82. Focal cerebral β-amyloid angiopathy: A distinct clinicopathologic presentation. Neurol Clin Pract. 2017 Oct; 7(5):444-448. Karageorgiou E, Naasan G, Pleasure SJ, Alexandrescu S, Gelfand JM, Tammewar G, Miller BL, Rabinovici GD, Grinberg LT. PMID: 29620074; PMCID: PMC5874474.
      View in: PubMed   Mentions:
    83. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions. J Neurol Sci. 2017 Oct 15; 381:83-87. Tremblay MA, Villanueva-Meyer JE, Cha S, Tihan T, Gelfand JM. PMID: 28991721; PMCID: PMC5659762.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    84. Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort. Lung. 2017 Oct; 195(5):553-561. Benn BS, Lehman Z, Kidd SA, Ho M, Sun S, Ramstein J, Arger NK, Nguyen CP, Su R, Gomez A, Gelfand JM, Koth LL. PMID: 28707108.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    85. Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis. Sci Transl Med. 2017 04 12; 9(385). Ward ME, Chen R, Huang HY, Ludwig C, Telpoukhovskaia M, Taubes A, Boudin H, Minami SS, Reichert M, Albrecht P, Gelfand JM, Cruz-Herranz A, Cordano C, Alavi MV, Leslie S, Seeley WW, Miller BL, Bigio E, Mesulam MM, Bogyo MS, Mackenzie IR, Staropoli JF, Cotman SL, Huang EJ, Gan L, Green AJ. PMID: 28404863; PMCID: PMC5526610.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansAnimalsCells
    86. Risk of Multiple Sclerosis After a Clinically Isolated Syndrome: From Magnetic Resonance Imaging to Oligoclonal Bands to Activated T Cells. JAMA Neurol. 2017 03 01; 74(3):262-263. Gelfand JM. PMID: 28055077.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    87. Retinal thinning is uniquely associated with medial temporal lobe atrophy in neurologically normal older adults. Neurobiol Aging. 2017 03; 51:141-147. Casaletto KB, Ward ME, Baker NS, Bettcher BM, Gelfand JM, Li Y, Chen R, Dutt S, Miller B, Kramer JH, Green AJ. PMID: 28068565; PMCID: PMC5554591.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    88. Continuous daily assessment of multiple sclerosis disability using remote step count monitoring. J Neurol. 2017 Feb; 264(2):316-326. Block VJ, Lizée A, Crabtree-Hartman E, Bevan CJ, Graves JS, Bove R, Green AJ, Nourbakhsh B, Tremblay M, Gourraud PA, Ng MY, Pletcher MJ, Olgin JE, Marcus GM, Allen DD, Cree BA, Gelfand JM. PMID: 27896433; PMCID: PMC5292081.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    89. Long-term evolution of multiple sclerosis disability in the treatment era. Ann Neurol. 2016 10; 80(4):499-510. University of California, San Francisco MS-EPIC Team:, Cree BA, Gourraud PA, Oksenberg JR, Bevan C, Crabtree-Hartman E, Gelfand JM, Goodin DS, Graves J, Green AJ, Mowry E, Okuda DT, Pelletier D, von Büdingen HC, Zamvil SS, Agrawal A, Caillier S, Ciocca C, Gomez R, Kanner R, Lincoln R, Lizee A, Qualley P, Santaniello A, Suleiman L, Bucci M, Panara V, Papinutto N, Stern WA, Zhu AH, Cutter GR, Baranzini S, Henry RG, Hauser SL. PMID: 27464262; PMCID: PMC5105678.
      View in: PubMed   Mentions: 140     Fields:    Translation:Humans
    90. Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis. Ann Rheum Dis. 2017 Mar; 76(3):543-546. Miloslavsky EM, Naden RP, Bijlsma JW, Brogan PA, Brown ES, Brunetta P, Buttgereit F, Choi HK, DiCaire JF, Gelfand JM, Heaney LG, Lightstone L, Lu N, Murrell DF, Petri M, Rosenbaum JT, Saag KS, Urowitz MB, Winthrop KL, Stone JH. PMID: 27474764.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    91. Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study. J Neurol. 2016 Jul; 263(7):1323-31. Balk LJ, Cruz-Herranz A, Albrecht P, Arnow S, Gelfand JM, Tewarie P, Killestein J, Uitdehaag BM, Petzold A, Green AJ. PMID: 27142714; PMCID: PMC4929170.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    92. Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review. PLoS One. 2016; 11(4):e0154335. Block VA, Pitsch E, Tahir P, Cree BA, Allen DD, Gelfand JM. PMID: 27124611; PMCID: PMC4849800.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    93. Development of a Diagnostic Decision Tree for Rapidly Progressive Dementia (P5.182). Neurology. 2016 Apr 5; 86(16_supplement). Gelfand GJ, Fredericks FC, Rabinowitz RN, Rankin RK, Hess HC, Paoletti PM, Higgins HJ, Williams WG, Miller MB, Rosen RH, Geschwind GM. .
      View in: Publisher Site   Mentions:
    94. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016 Apr; 15(4):391-404. Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J. PMID: 26906964; PMCID: PMC5066574.
      View in: PubMed   Mentions: 1215     Fields:    Translation:Humans
    95. The severe side of the IgG4-related hypertrophic pachymeningitis disease spectrum. Neurol Neuroimmunol Neuroinflamm. 2016 Feb; 3(1):e197. Schubert RD, Wood M, Levin MH, Perry A, Gelfand JM. PMID: 26770998; PMCID: PMC4708924.
      View in: PubMed   Mentions: 4     Fields:    
    96. One Brain, Two Specialties, Converging Mechanisms: Neuronal Autoantibodies as a Rare Cause of Postpartum Psychosis. Am J Psychiatry. 2015 Sep 01; 172(9):824-6. Gelfand JM. PMID: 26324300.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    97. Diagnosing Balamuthia mandrillaris Encephalitis With Metagenomic Deep Sequencing. Ann Neurol. 2015 Nov; 78(5):722-30. Wilson MR, Shanbhag NM, Reid MJ, Singhal NS, Gelfand JM, Sample HA, Benkli B, O'Donovan BD, Ali IK, Keating MK, Dunnebacke TH, Wood MD, Bollen A, DeRisi JL. PMID: 26290222; PMCID: PMC4624031.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimals
    98. Neurosarcoidosis. In: Samuels M, editor. Scientific American Neurology. 2015. Gelfand JM Stern BJ. View Publication.
    99. Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis. JAMA Neurol. 2015 Aug; 72(8):897-904. Schlaeger R, Papinutto N, Zhu AH, Lobach IV, Bevan CJ, Bucci M, Castellano A, Gelfand JM, Graves JS, Green AJ, Jordan KM, Keshavan A, Panara V, Stern WA, von Büdingen HC, Waubant E, Goodin DS, Cree BA, Hauser SL, Henry RG. PMID: 26053119; PMCID: PMC6002864.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    100. Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients. Neurology. 2015 Jun 16; 84(24):2403-12. Höftberger R, van Sonderen A, Leypoldt F, Houghton D, Geschwind M, Gelfand J, Paredes M, Sabater L, Saiz A, Titulaer MJ, Graus F, Dalmau J. PMID: 25979696; PMCID: PMC4478035.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansCells
    101. Therapeutic management of severe relapses in multiple sclerosis. Curr Treat Options Neurol. 2015 Apr; 17(4):345. Bevan C, Gelfand JM. PMID: 25794777.
      View in: PubMed   Mentions: 15  
    102. Harrison's Principles of Internal Medicine. 19th Edition. Edited by Dennis L. Kasper, Anthony S. Fauci, Stephen L. Hauser, Dan L. Longo, J. Larry Jameson, Joseph Loscalzo. Chapter 29: Fatigue. 2015; 151-153. Gelfand, JM. Douglas, VC. View Publication.
    103. Encephalitis of unclear origin diagnosed by brain biopsy: a diagnostic challenge. JAMA Neurol. 2015 Jan; 72(1):66-72. Gelfand JM, Genrich G, Green AJ, Tihan T, Cree BA. PMID: 25365755.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    104. Precision medicine in chronic disease management: The multiple sclerosis BioScreen. Ann Neurol. 2014 Nov; 76(5):633-42. Gourraud PA, Henry RG, Cree BA, Crane JC, Lizee A, Olson MP, Santaniello AV, Datta E, Zhu AH, Bevan CJ, Gelfand JM, Graves JS, Goodin DS, Green AJ, von Büdingen HC, Waubant E, Zamvil SS, Crabtree-Hartman E, Nelson S, Baranzini SE, Hauser SL. PMID: 25263997; PMCID: PMC4214886.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    105. Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO. Neurol Neuroimmunol Neuroinflamm. 2014 Oct; 1(3):e34. Gelfand JM, Cotter J, Klingman J, Huang EJ, Cree BA. PMID: 25340086; PMCID: PMC4204228.
      View in: PubMed   Mentions: 31     Fields:    
    106. Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis. JAMA Neurol. 2014 Oct; 71(10):1300-4. Naasan G, Irani SR, Bettcher BM, Geschwind MD, Gelfand JM. PMID: 25133690; PMCID: PMC4474144.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    107. Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD. J Exp Med. 2014 Sep 22; 211(10):1937-45. Ward ME, Taubes A, Chen R, Miller BL, Sephton CF, Gelfand JM, Minami S, Boscardin J, Martens LH, Seeley WW, Yu G, Herz J, Filiano AJ, Arrant AE, Roberson ED, Kraft TW, Farese RV, Green A, Gan L. PMID: 25155018; PMCID: PMC4172214.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimals
    108. Spinal cord gray matter atrophy correlates with multiple sclerosis disability. Ann Neurol. 2014 Oct; 76(4):568-80. Schlaeger R, Papinutto N, Panara V, Bevan C, Lobach IV, Bucci M, Caverzasi E, Gelfand JM, Green AJ, Jordan KM, Stern WA, von Büdingen HC, Waubant E, Zhu AH, Goodin DS, Cree BA, Hauser SL, Henry RG. PMID: 25087920; PMCID: PMC5316412.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    109. Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann Neurol. 2014 Aug; 76(2):168-84. Irani SR, Gelfand JM, Al-Diwani A, Vincent A. PMID: 24930434; PMCID: PMC4141019.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    110. Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy. JAMA Neurol. 2014 Jul 01; 71(7):896-900. Irani SR, Gelfand JM, Bettcher BM, Singhal NS, Geschwind MD. PMID: 24842754; PMCID: PMC4477824.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    111. More than memory impairment in voltage-gated potassium channel complex encephalopathy. Eur J Neurol. 2014 Oct; 21(10):1301-10. Bettcher BM, Gelfand JM, Irani SR, Neuhaus J, Forner S, Hess CP, Geschwind MD. PMID: 24981998; PMCID: PMC4162838.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    112. The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18; 31(1):19-27. Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, Shigemitsu H, Culver DA, Gelfand J, Valeyre D, Sweiss N, Crouser E, Morgenthau AS, Lower EE, Azuma A, Ishihara M, Morimoto S, Tetsuo Yamaguchi T, Shijubo N, Grutters JC, Rosenbach M, Li HP, Rottoli P, Inoue Y, Prasse A, Baughman RP, Organ Assessment Instrument Investigators TW. PMID: 24751450.
      View in: PubMed   Mentions: 166     Fields:    Translation:Humans
    113. Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentation. Handb Clin Neurol. 2014; 122:269-90. Gelfand JM. PMID: 24507522.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    114. Microcystic inner nuclear layer abnormalities and neuromyelitis optica. JAMA Neurol. 2013 May; 70(5):629-33. Gelfand JM, Cree BA, Nolan R, Arnow S, Green AJ. PMID: 23529376.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    115. Migraine and multiple sclerosis: Epidemiology and approach to treatment. Mult Scler Relat Disord. 2013 Apr; 2(2):73-9. Gelfand AA, Gelfand JM, Goadsby PJ. PMID: 25877626.
      View in: PubMed   Mentions: 11     Fields:    
    116. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol. 2013 Jan; 73(1):120-8. Boronat A, Gelfand JM, Gresa-Arribas N, Jeong HY, Walsh M, Roberts K, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R, Graus F, Rudy B, Dalmau J. PMID: 23225603; PMCID: PMC3563722.
      View in: PubMed   Mentions: 115     Fields:    Translation:HumansAnimalsCells
    117. Fingolimod treatment in multiple sclerosis leads to increased macular volume. Neurology. 2013 Jan 08; 80(2):139-44. Nolan R, Gelfand JM, Green AJ. PMID: 23223539; PMCID: PMC3589191.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    118. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol. 2012 Nov; 11(11):963-72. Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, Ratchford JN, Oh J, Seigo MA, Newsome SD, Balcer LJ, Frohman EM, Green AJ, Nguyen QD, Calabresi PA. PMID: 23041237; PMCID: PMC3533139.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCells
    119. Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. PLoS One. 2012; 7(5):e36847. Gelfand JM, Goodin DS, Boscardin WJ, Nolan R, Cuneo A, Green AJ. PMID: 22666330; PMCID: PMC3359324.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    120. Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. 2012 Jun; 135(Pt 6):1786-93. Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ. PMID: 22539259; PMCID: PMC3359753.
      View in: PubMed   Mentions: 119     Fields:    Translation:Humans
    121. Neurology Now. Should I see a neurologist for sarcoidosis?. 2012; 1(8):31. Gelfand JM. View Publication.
    122. Color vision is strongly associated with retinal thinning in multiple sclerosis. Mult Scler. 2012 Jul; 18(7):991-9. Villoslada P, Cuneo A, Gelfand J, Hauser SL, Green A. PMID: 22291035.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    123. Ophthalmoplegic "migraine" or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review. J Child Neurol. 2012 Jun; 27(6):759-66. Gelfand AA, Gelfand JM, Prabakhar P, Goadsby PJ. PMID: 22241707; PMCID: PMC3562350.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    124. Vitamin D in African Americans with multiple sclerosis. Neurology. 2011 May 24; 76(21):1824-30. Gelfand JM, Cree BA, McElroy J, Oksenberg J, Green R, Mowry EM, Miller JW, Hauser SL, Green AJ. PMID: 21606454; PMCID: PMC3100123.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    125. Heterogeneous patterns of tissue injury in NARP syndrome. J Neurol. 2011 Mar; 258(3):440-8. Gelfand JM, Duncan JL, Racine CA, Gillum LA, Chin CT, Zhang Y, Zhang Q, Wong LJ, Roorda A, Green AJ. PMID: 20953793; PMCID: PMC3068520.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    126. Cardiac rupture after intravenous t-PA administration in acute ischemic stroke. Neurocrit Care. 2010 Oct; 13(2):261-2. Dhand A, Nakagawa K, Nagpal S, Gelfand JM, Kim AS, Smith WS, Tihan T. PMID: 20697837.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    127. Cerebral perfusion-CT patterns following seizure. Eur J Neurol. 2010 Apr; 17(4):594-601. Gelfand JM, Wintermark M, Josephson SA. PMID: 19968701.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    128. Speech-activated myoclonus masquerading as stuttering. Neurology. 2009 Jun 02; 72(22):1964. Gelfand JM, Nelson AB, Fross RD, Glass GA. PMID: 19487657.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Jeffrey's Networks
    Concepts (390)
    Derived automatically from this person's publications.
    _
    Co-Authors (135)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _